MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma

Documenti analoghi

• MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells
  di: Yang, Shih-Wei, et al.
  Pubblicazione: (2016)
• 25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)(2)D(3)
  di: Chiang, Kun-Chun, et al.
  Pubblicazione: (2016)
• The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential
  di: Chiang, Kun-Chun, et al.
  Pubblicazione: (2016)
• Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker
  di: Chiang, Kun-Chun, et al.
  Pubblicazione: (2016)
• MART-10, a New Generation of Vitamin D Analog, Is More Potent than 1α,25-Dihydroxyvitamin D(3) in Inhibiting Cell Proliferation and Inducing Apoptosis in ER+ MCF-7 Breast Cancer Cells
  di: Chiang, Kun-Chun, et al.
  Pubblicazione: (2012)